Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

The urgent need for vaccines against Ebola virus (EBOV) was underscored by the large outbreak in West Africa (2014–2016). Since then, several promising vaccine candidates have been tested in pre-clinical and clinical studies. As a result, two vaccines were approved for human use in 2019/2020, of...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Kupke, Alexandra, Dietzel, Erik, Schmidt, Jörg, Shams-Eldin, Hosam, Sauerhering, Lucie, Krähling, Verena, Gellhorn Serra, Michelle, Eickmann, Markus, Becker, Stephan
स्वरूप: लेख
भाषा:अंग्रेज़ी
प्रकाशित: Philipps-Universität Marburg 2023
विषय:
ऑनलाइन पहुंच:पीडीएफ पूर्ण पाठ
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

इंटरनेट

पीडीएफ पूर्ण पाठ

होल्डिंग्स विवरण से
बोधानक: urn:nbn:de:hebis:04-es2023-00054
प्रकाशन तिथि: 2023-03-06
स्रोत: Erstveröffentlichung: Kupke, A.; Volz, A.; Dietzel, E.; Freudenstein, A.; Schmidt, J.; Shams-Eldin, H.; Jany, S.; Sauerhering, L.; Krähling, V.; Gellhorn Serra, M.; et al. Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. Vaccines 2022, 10, 533. https://doi.org/10.3390/vaccines10040533
Downloads: 23 (2024), 32 (2023)
Lizenz: https://creativecommons.org/licenses/by/4.0
यूआरएल में प्रवेश करें: https://archiv.ub.uni-marburg.de/es/2023/0005
https://doi.org/10.3390/vaccines10040533